Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
Cornely, Oliver A, Robertson, Michael N, Haider, Shariq, Grigg, Andrew, Geddes, Michelle, Aoun, Mickael, Heinz, Werner J, Raad, Issam, Schanz, Urs, Meyer, Ralf G, Hammond, Sarah P, Mullane, Kathleen MVolume:
72
Language:
english
Journal:
Journal of Antimicrobial Chemotherapy
DOI:
10.1093/jac/dkx382
Date:
December, 2017
File:
PDF, 57 KB
english, 2017